Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Elevation Oncology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ELEV
Nasdaq
8731
https://elevationoncology.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Elevation Oncology Inc
7 Top Stocks Under $7
- Apr 11th, 2024 10:40 am
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
- Apr 8th, 2024 8:30 pm
Elevation Oncology Inc (ELEV) Reports Financial Results for Q4 and Full Year 2023
- Mar 7th, 2024 6:54 pm
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
- Mar 6th, 2024 12:30 pm
Trim the Fat: 3 Overbought Stocks Poised for a Pullback
- Mar 5th, 2024 11:00 pm
Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
- Mar 5th, 2024 9:30 pm
Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors
- Mar 4th, 2024 12:30 pm
Elevation Oncology to Participate in Upcoming Investor Conferences
- Feb 28th, 2024 12:30 pm
3 Stock Winners That Are Up 400% or More in 2024
- Feb 23rd, 2024 2:17 pm
Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan
- Feb 22nd, 2024 12:30 pm
Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
- Jan 22nd, 2024 12:30 pm
With 29% ownership in Elevation Oncology, Inc. (NASDAQ:ELEV), hedge funds investors have a lot riding on the business
- Jan 13th, 2024 1:09 pm
Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
- Jan 5th, 2024 12:30 pm
Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference
- Nov 22nd, 2023 12:30 pm
Elevation Oncology Inc (ELEV) Reports Q3 2023 Financial Results
- Nov 2nd, 2023 1:40 pm
Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements
- Nov 2nd, 2023 11:30 am
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 5th, 2023 11:30 am
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021
- Aug 16th, 2023 11:30 am
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements
- Aug 3rd, 2023 11:30 am
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer
- Jul 13th, 2023 12:00 pm
Scroll